625 related articles for article (PubMed ID: 29514796)
1. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
2. Bone secreted factors induce cellular quiescence in prostate cancer cells.
Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH
Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067
[TBL] [Abstract][Full Text] [Related]
3. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
4. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
5. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.
Yumoto K; Eber MR; Wang J; Cackowski FC; Decker AM; Lee E; Nobre AR; Aguirre-Ghiso JA; Jung Y; Taichman RS
Sci Rep; 2016 Nov; 6():36520. PubMed ID: 27819283
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor β (TGFβ) signaling.
Karlsson T; Sundar R; Widmark A; Landström M; Persson E
Prostate; 2018 May; 78(6):446-456. PubMed ID: 29383751
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
Zayzafoon M; Abdulkadir SA; McDonald JM
J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
[TBL] [Abstract][Full Text] [Related]
10. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET
Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
[TBL] [Abstract][Full Text] [Related]
13. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.
Yu G; Lee YC; Cheng CJ; Wu CF; Song JH; Gallick GE; Yu-Lee LY; Kuang J; Lin SH
Mol Cancer Res; 2015 Feb; 13(2):348-57. PubMed ID: 25189355
[TBL] [Abstract][Full Text] [Related]
14. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.
Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103
[TBL] [Abstract][Full Text] [Related]
16. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.
Wang N; Docherty FE; Brown HK; Reeves KJ; Fowles AC; Ottewell PD; Dear TN; Holen I; Croucher PI; Eaton CL
J Bone Miner Res; 2014 Dec; 29(12):2688-96. PubMed ID: 24956445
[TBL] [Abstract][Full Text] [Related]
18. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET
Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.
Kobayashi A; Okuda H; Xing F; Pandey PR; Watabe M; Hirota S; Pai SK; Liu W; Fukuda K; Chambers C; Wilber A; Watabe K
J Exp Med; 2011 Dec; 208(13):2641-55. PubMed ID: 22124112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]